ROSWELL, Ga. -- Kimberly-Clark announces that Lynne Kelley, MD, FACS, has been named to the newly created position of vice president, medical director, for the companys $1.2 billion healthcare business. Effective Nov. 5, Kelley assumed responsibilities for the development and delivery of Kimberly-Clark Health Cares clinical strategy and education development, as well as the global coordination of professional and governmental relations.
We are pleased to have Lynne on board to help drive our clinical strategy and look forward to her many contributions, said Kimberly-Clark Health Care president Joanne Bauer. Lynnes impressive credentials and medical expertise will be invaluable to us as we expand our portfolio of medical devices and products to prevent healthcare associated infections.
Kelley is a board-certified general and vascular surgeon who received her medical degree from Dartmouth Medical School and completed her residency in general surgery at Dartmouth Hitchcock Medical Center. During her training, she was awarded an NIH sponsored research grant at Harvard Medical School. Kelley completed a fellowship in vascular surgery at Harvard Medical School at Massachusetts General Hospital and was the recipient of the Marco Polo Fellowship that provided further training in endovascular surgery at the Hospital Henri Mondor, University Paris XII in Créteil, France. Prior to working in the industry, Kelley was an assistant professor of vascular surgery and radiology at Yale University.
I am very excited to be joining the healthcare team at Kimberly-Clark and to be part of a company whose mission is to improve the lives of people worldwide, said Kelley.
Kimberly-Clark is striving to bring its healthcare customers less worry through delivery of clinical solutions to prevent, diagnose and manage healthcare-associated infections and to prevent or reduce complications before, during and after surgery.
Source: Kimberly-Clark Health Care
Â
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.